Rezultati pretraživanja
  1. prije 16 sati

    acc. to company, it is not sure whether we will see full data release ZW49 phase 1 at ASCO (as originally guided) or at a later medical meeting. they want to dose-escalate up to MTD for efficacy reasons -> I assume we will not see P1 data at ASCO as originally guided

  2. prije 18 sati

    IMO There is zero selling of any substance in the stock to even be slightly worried about. This is just people taking advantage of no volume short flipping hundreds of shares at a time

  3. prije 21 sat

    Looks like they power the box on at 9:35 AM

  4. 5. velj

    Zymeworks Trading 5% Higher Following Analyst Upgrade

  5. 5. velj

    -Stifel:"ZW49 update . . with the completion of dose-escalation (and not committing to a specific medical conference) will allow for a more-comprehensive understanding of (likely widened) ZW49 therapeutic index . . $1.25B in peak WW ZW49 sales in 2L-4L HER2+ breast cancer"

  6. 4. velj
  7. 4. velj

    finally ready to go here?

  8. 4. velj

    I have further investigated the matter: has a bystander effect in contrast to T-DM1! Very important is also that ZW49 is internalized much better than the other ADCs. For this reason a therapeutic effect should be expected even at very low HER2 expression.

  9. 3. velj

    IMO, this added with the 300 million raised at $46.50 should be the minimum this stock trades at

  10. 3. velj
  11. 3. velj
    Odgovor korisniku/ci
  12. 2. velj

    Neg.: should not have a notable bystander effect Pos.: Compared with other ADCs, internalization is significantly increased. On balance ZW49 has been successfully preclinically tested on low HER2-expressing patient derived xenograft models.

    Prikaži ovu nit
  13. 1. velj

    Top 5 Stocks for 2020 up 12.93% vs. -.16% for the S&P : Usually marks a short term top when I post this :)

  14. 31. sij
  15. 30. sij
    Odgovor korisniku/ci

    Nice! Long

  16. 30. sij

    notable $350k insider buy in

  17. 30. sij

    Zymeworks Inc Given Average Recommendation of “Buy” by Brokerages

  18. 29. sij
  19. 29. sij

    My guess is studies are going extremely well showing good activity and low AE’s. I’m confident that Zw49 beats DS-8201 in AE’s. Are they as active is the question? If not what’s the fine line between efficiency and AE’s?

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.